Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer

Breast cancer is the most common female cancer, affecting approximately one in eight women during their lifetime in North America and Europe. Receptor Activator of NF-kB Ligand (RANKL), its receptor RANK and the natural antagonist osteoprotegerin (OPG) are essential regulators of bone resorption. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiechl, Stefan, Schramek, Daniel, Widschwendter, Martin, Fourkala, Evangelia-Ourania, Zaikin, Alexey, Jones, Allison, Jaeger, Bernadette, Rack, Brigitte, Janni, Wolfgang, Scholz, Christoph, Willeit, Johann, Weger, Siegfried, Mayr, Agnes, Teschendorff, Andrew, Rosenthal, Adam, Fraser, Lindsay, Philpott, Susan, Dubeau, Louis, Keshtgar, Mohammed, Roylance, Rebecca, Jacobs, Ian J., Menon, Usha, Schett, Georg, Penninger, Josef M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354797/
https://www.ncbi.nlm.nih.gov/pubmed/28002811
http://dx.doi.org/10.18632/oncotarget.14013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354797/
https://www.ncbi.nlm.nih.gov/pubmed/28002811
http://dx.doi.org/10.18632/oncotarget.14013

Ejemplares similares